I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption ...

Given this risk, we thought we'd take a look at whether 10x Genomics (NASDAQ:TXG) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative ...

Here are three reasons why there are better opportunities than TXG and a stock we'd rather own. Founded in 2012, 10x Genomics (NASDAQ:TXG) develops single-cell and spatial genomics solutions ...

Microsoft says a coding issue is behind a now-resolved Microsoft 365 outage over the weekend that affected Outlook and Exchange Online authentication. According to an incident report published ...

Shares of NASDAQ:TXG opened at $9.41 on Friday. The company has a market cap of $1.15 billion, a price-to-earnings ratio of -6.19 and a beta of 1.93. 10x Genomics, Inc. has a 12 month low of $9.27 ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the 4th quarter, according to the company in its most recent filing with ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa ...

If you use Word, Excel, PowerPoint, or any of the Microsoft 365 suite of applications, I have one question for you: Why are you paying full price for your software? If the answer is because you ...

Get the latest info on new features, bug fixes, and security updates for Microsoft 365/Office 365 for Windows as they roll out from Microsoft. Now updated for Version 2502 (Build 18526.20168 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...